Identification of a Wilms' tumor 1-derived immunogenic CD4+ T-cell epitope that is recognized in the context of common Caucasian HLA-DR haplotypes

被引：7

作者：

Anguille, S. ^{[1
,2
]}

Fujiki, F. ^{[3
]}

Smits, E. L. ^{[1
,2
]}

Oji, Y. ^{[4
]}

Lion, E. ^{[2
]}

Oka, Y. ^{[5
]}

Berneman, Z. N. ^{[1
,2
]}

Sugiyama, H. ^{[6
]}

机构：

[1] Univ Antwerp Hosp, Ctr Cell Therapy & Regenerat Med, Antwerp, Belgium

[2] Univ Antwerp, Lab Expt Hematol, Vaccine & Infect Dis Inst VAXINFECTIO, B-2020 Antwerp, Belgium

[3] Osaka Univ, Grad Sch Med, Dept Canc Immunol, Osaka, Japan

[4] Dept Canc Stem Cell Biol, Osaka, Japan

[5] Dept Resp Med Allergy & Rheumat Dis, Osaka, Japan

[6] Dept Funct Diagnost Sci, Osaka, Japan

来源：

LEUKEMIA | 2013年 / 27卷 / 03期

关键词：

WT1 PEPTIDE VACCINATION; ACUTE MYELOID-LEUKEMIA; INDUCTION; RESPONSES; MALIGNANCIES;

D O I：

10.1038/leu.2012.248

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：748 / 750

页数：3

共 15 条

[1]

Leukemia-associated antigens and their relevance to the immunotherapy of acute myeloid leukemia [J].

Anguille, S. ;

Van Tendeloo, V. F. ;

Berneman, Z. N. .

LEUKEMIA, 2012, 26 (10) :2186-2196

[2]

Dendritic cell vaccine therapy for acute myeloid leukemia Questions and answers [J].

Anguille, Sebastien ;

Lion, Eva ;

Smits, Evelien ;

Berneman, Zwi N. ;

van Tendeloo, Viggo F. I. .

HUMAN VACCINES, 2011, 7 (05) :579-584

[3]

Vaccination with Recombinant NY-ESO-1 Protein Elicits Immunodominant HLA-DR52b-restricted CD4+ T Cell Responses with a Conserved T Cell Receptor Repertoire [J].

Bioley, Gilles ;

Dousset, Christelle ;

Yeh, Alice ;

Dupont, Bo ;

Bhardwaj, Nina ;

Mears, Gregory ;

Old, Lloyd J. ;

Ayyoub, Maha ;

Valmori, Danila .

CLINICAL CANCER RESEARCH, 2009, 15 (13) :4467-4474

[4]

A live-cell assay to detect antigen-specific CD4+ T cells with diverse cytokine profiles [J].

Chattopadhyay, PK ;

Yu, J ;

Roederer, M .

NATURE MEDICINE, 2005, 11 (10) :1113-1117

[5]

Reassessing the role of HLA-DRB3 T-cell responses: Evidence for significant expression and complementary antigen presentation [J].

Faner, Rosa ;

James, Eddie ;

Huston, Laurie ;

Pujol-Borrel, Ricardo ;

Kwok, William W. ;

Juan, Manel .

EUROPEAN JOURNAL OF IMMUNOLOGY, 2010, 40 (01) :91-102

[6]

Fujiki F, 2010, ANTICANCER RES, V30, P2247

[7]

A WT1 protein-derived, naturally processed 16-mer peptide, WT1332, is a promiscuous helper peptide for induction of WT1-specific Th1-type CD4+ T cells [J].

Fujiki, Fumihiro ;

Oka, Yoshihiro ;

Kawakatsu, Mai ;

Tsuboi, Akihiro ;

Nakajima, Hiroko ;

Elisseeva, Olga A. ;

Harada, Yukie ;

Li, Zheyu ;

Tatsumi, Naoko ;

Kamino, Eriko ;

Shirakata, Toshiaki ;

Nishida, Sumiyuki ;

Taniguchi, Yuki ;

Kawase, Ichiro ;

Oji, Yusuke ;

Sugiyama, Haruo .

MICROBIOLOGY AND IMMUNOLOGY, 2008, 52 (12) :591-600

[8]

Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations [J].

Gonzalez-Galarza, Faviel F. ;

Christmas, Stephen ;

Middleton, Derek ;

Jones, Andrew R. .

NUCLEIC ACIDS RESEARCH, 2011, 39 :D913-D919

[9]

A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS [J].

Keilholz, Ulrich ;

Letsch, Anne ;

Busse, Antonia ;

Asemissen, Anne Marie ;

Bauer, Sandra ;

Blau, Igor Wolfgang ;

Hofmann, Wolf-Karsten ;

Uharek, Lutz ;

Thiel, Eckhard ;

Scheibenbogen, Carmen .

BLOOD, 2009, 113 (26) :6541-6548

[10]

Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression [J].

Oka, Y ;

Tsuboi, A ;

Taguchi, T ;

Osaki, T ;

Kyo, T ;

Nakajima, H ;

Elisseeva, OA ;

Oji, Y ;

Kawakami, M ;

Ikegame, K ;

Hosen, N ;

Yoshihara, S ;

Wu, F ;

Fujiki, F ;

Murakami, M ;

Masuda, T ;

Nishida, S ;

Shirakata, T ;

Nakatsuka, S ;

Sasaki, A ;

Udaka, K ;

Dohy, H ;

Aozasa, K ;

Noguchi, S ;

Kawase, L ;

Sugiyama, H .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (38) :13885-13890

← 1 2 →